Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature
P Dorfmüller, S Günther, MR Ghigna… - European …, 2014 - Eur Respiratory Soc
Limited numbers of operated patients with chronic thromboembolic pulmonary hypertension
(CTEPH) are refractory to pulmonary endarterectomy (PEA) and experience persistent …
(CTEPH) are refractory to pulmonary endarterectomy (PEA) and experience persistent …
Retrospective institutional study of 31 patients treated for pulmonary artery sarcoma
S Mussot, MR Ghigna, O Mercier… - European Journal of …, 2013 - academic.oup.com
OBJECTIVES The study aimed to determine the optimal surgical procedure to treat pulmonary
artery sarcomas responsible for pulmonary hypertension. METHODS Between 1997 and …
artery sarcomas responsible for pulmonary hypertension. METHODS Between 1997 and …
[HTML][HTML] Small-cell carcinoma in the setting of pulmonary adenocarcinoma: new insights in the era of molecular pathology
E Norkowski, MR Ghigna, L Lacroix… - Journal of Thoracic …, 2013 - Elsevier
Introduction Transformation into small-cell lung carcinoma (SCLC) has been reported as an
evolution of lung adenocarcinoma acquiring resistance to epidermal growth factor receptor (…
evolution of lung adenocarcinoma acquiring resistance to epidermal growth factor receptor (…
Solitary fibrous tumor of the pleura: outcomes of 157 complete resections in a single center
B Lahon, O Mercier, E Fadel, MR Ghigna… - The Annals of thoracic …, 2012 - Elsevier
BACKGROUND: The purpose of this study was to identify factors affecting long-term outcomes
after complete resection of solitary fibrous tumors of the pleura (SFTP). METHODS: This …
after complete resection of solitary fibrous tumors of the pleura (SFTP). METHODS: This …
BMPR2 mutation status influences bronchial vascular changes in pulmonary arterial hypertension
MR Ghigna, C Guignabert, D Montani… - European …, 2016 - Eur Respiratory Soc
The impact of bone morphogenetic protein receptor 2 (BMPR2) gene mutations on vascular
remodelling in pulmonary arterial hypertension (PAH) is unknown. We sought to identify a …
remodelling in pulmonary arterial hypertension (PAH) is unknown. We sought to identify a …
Orai1 inhibitors as potential treatments for pulmonary arterial hypertension
…, Y Ruchon, M Dutheil, A Boët, MR Ghigna… - Circulation …, 2022 - Am Heart Assoc
Background: Pulmonary arterial hypertension (PAH) is characterized by progressive distal
pulmonary artery (PA) obstruction, leading to right ventricular hypertrophy and failure. …
pulmonary artery (PA) obstruction, leading to right ventricular hypertrophy and failure. …
[PDF][PDF] Patient‐derived mouse xenografts from pediatric liver cancer predict tumor recurrence and advise clinical management
…, C Guettier, MJ Redon, L Brugières, MR Ghigna… - …, 2016 - Wiley Online Library
Identification of new treatments for relapsing pediatric cancer is an unmet clinical need and a
societal challenge. Liver cancer occurrence in infancy, 1.5 for million children per year, falls …
societal challenge. Liver cancer occurrence in infancy, 1.5 for million children per year, falls …
[HTML][HTML] RET-MAP: An international multicenter study on clinicobiologic features and treatment response in patients with lung cancer harboring a RET fusion
…, A Cortellini, C Leonce, A Gazzah, MR Ghigna… - Journal of Thoracic …, 2023 - Elsevier
Introduction Nearly 1% to 2% of NSCLCs harbor RET fusions. Characterization of this rare
population is still incomplete. Methods This retrospective multicenter study included patients …
population is still incomplete. Methods This retrospective multicenter study included patients …
Type or extension of intestinal metaplasia and immature/atypical “indefinite-for-dysplasia” lesions as predictors of gastric neoplasia
F Tava, O Luinetti, MR Ghigna, C Alvisi, M Perego… - Human pathology, 2006 - Elsevier
At present, no information exists on the neoplastic potential of the immature hyperproliferative
and atypical lesions of the gastric mucosa, which have been recently labeled “indefinite for …
and atypical lesions of the gastric mucosa, which have been recently labeled “indefinite for …
Multimodal imaging mass spectrometry to identify markers of pulmonary arterial hypertension in human lung tissue using MALDI-ToF, ToF-SIMS, and hybrid SIMS
…, SJ Dumas, MK Nakhleh, MR Ghigna… - Analytical …, 2020 - ACS Publications
Pulmonary arterial hypertension (PAH) is a rare and deadly disease affecting roughly 15–60
people per million in Europe with a poorly understood pathology. There are currently no …
people per million in Europe with a poorly understood pathology. There are currently no …